GlassScriptPhysician profile
Timothy Michael Kamp
NPI 1932633443
$2,252.84
in general payments reported to CMS, 2019-2025
18 companies · $1,348 in 2025
The $1,348 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $94.29 · 2023: $461 · 2024: $222 · 2025: $1,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050 · Travel and Lodging: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,050.21 |
| Travel and Lodging | $980.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $972.88 | 2021-2025 | |
| Arthrex, INC. | $626.40 | 2025 | |
| Stryker Corporation | $141.29 | 2023-2024 | Alphavent, Inspace |
| Pacira Pharmaceuticals Incorporated | $126.23 | 2022-2023 | Zilretta, Iovera, Exparel |
| Zimmer Biomet Holdings, INC. | $42.56 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $42.48 | 2024 | Monovisc |
| Amgen INC. | $40.51 | 2022-2023 | Evenity, Prolia |
| Ermi LLC | $35.42 | 2023 | |
| Axogen | $32.76 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $31.34 | 2022-2023 | Seglentis |
| Ferring Pharmaceuticals INC. | $27.11 | 2022-2024 | Euflexxa |
| Davol INC. | $25.74 | 2025 | |
| Skeletal Dynamics INC | $24.36 | 2024 | Geminus, Ijs, Align |
| Acera Surgical, INC. | $19.64 | 2024 | Restrata Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $19.07 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17.87 | 2023 | Intellis Adaptivestim |
| Fidia Pharma USA INC. | $15.27 | 2024 | Hymovis |
| Heron Therapeutics, INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Kamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.